NANNI, CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 3.059
NA - Nord America 2.675
EU - Europa 2.021
SA - Sud America 188
AF - Africa 170
OC - Oceania 3
Totale 8.116
Nazione #
US - Stati Uniti d'America 2.638
SG - Singapore 818
VN - Vietnam 815
CN - Cina 791
IT - Italia 386
GB - Regno Unito 368
DE - Germania 335
SE - Svezia 245
HK - Hong Kong 209
IN - India 130
FR - Francia 126
BR - Brasile 123
FI - Finlandia 120
RU - Federazione Russa 107
NL - Olanda 94
KR - Corea 80
IE - Irlanda 65
JP - Giappone 53
CI - Costa d'Avorio 44
TG - Togo 42
ZA - Sudafrica 37
JO - Giordania 29
UA - Ucraina 29
SC - Seychelles 28
AR - Argentina 26
EE - Estonia 21
IQ - Iraq 21
AT - Austria 20
BG - Bulgaria 20
CA - Canada 20
CH - Svizzera 18
PH - Filippine 17
ID - Indonesia 16
BE - Belgio 15
ES - Italia 15
BD - Bangladesh 12
TR - Turchia 12
MX - Messico 11
NG - Nigeria 10
PL - Polonia 10
CL - Cile 9
EC - Ecuador 9
TH - Thailandia 9
IR - Iran 7
PY - Paraguay 7
PK - Pakistan 6
TW - Taiwan 6
HR - Croazia 5
SK - Slovacchia (Repubblica Slovacca) 5
CO - Colombia 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
VE - Venezuela 4
AL - Albania 3
AU - Australia 3
IL - Israele 3
LT - Lituania 3
MY - Malesia 3
OM - Oman 3
BN - Brunei Darussalam 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GY - Guiana 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 8.116
Città #
Singapore 562
Ashburn 342
Southend 308
Chandler 242
Hong Kong 200
Fairfield 179
Hanoi 170
Hefei 167
San Jose 156
Ho Chi Minh City 150
Seattle 114
Santa Clara 109
Munich 106
Helsinki 99
Beijing 98
Woodbridge 96
Houston 93
Dong Ket 89
Princeton 86
Wilmington 86
Cambridge 74
Seoul 70
Bologna 68
Dublin 65
Boardman 63
Los Angeles 52
Dallas 51
Ann Arbor 50
Lauterbourg 49
Tokyo 45
Abidjan 44
Lomé 42
Florence 40
New York 36
Berlin 32
Westminster 32
Frankfurt am Main 31
Nanjing 31
Amman 29
Council Bluffs 28
Haiphong 27
Da Nang 24
Buffalo 22
Redondo Beach 21
Guangzhou 20
Padova 20
Turin 19
Jinan 18
Milan 18
Bengaluru 17
Bremen 17
Tianjin 17
Saint Petersburg 16
Sofia 16
Bern 14
San Diego 14
Shenyang 14
Amsterdam 13
Brussels 13
Changsha 13
Chicago 13
Hebei 13
Jacksonville 13
Johannesburg 13
London 13
Orem 12
São Paulo 12
Nuremberg 11
Redmond 11
Nanchang 10
Rome 10
The Dalles 10
Abeokuta 9
Baghdad 9
Des Moines 9
Hangzhou 9
Jakarta 9
Redwood City 9
Shenzhen 9
Vienna 9
Brooklyn 8
Falls Church 8
Jiaxing 8
Medford 8
Quận Bình Thạnh 8
Tongling 8
Toronto 8
Wuhan 8
Biên Hòa 7
Haikou 7
Hyderabad 7
Hải Dương 7
Kuban 7
Mülheim 7
San Francisco 7
Shanghai 7
Turku 7
Yubileyny 7
Zhengzhou 7
Atlanta 6
Totale 5.097
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 338
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 304
A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae 257
18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial 221
Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone 221
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma 206
A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role? 203
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 200
Sclerosing Angiomatoid Nodular Transformation of the Adrenal Gland: A Case Report of a Novel Histopathological Entity 192
Potential Prognostic Role of 18F-FDG PET/CT in Invasive Epithelial Ovarian Cancer Relapse. A Preliminary Study 184
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma 182
Compa rison of 18F-fluciclovine PET/CT with 11 C-Choline PET/CT for nodal staging in prostate cancer: a prospective study 181
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literature 176
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 168
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 167
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients 167
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 167
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 166
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis 163
18F-FACBC PET/CT VS. 11C-CHOLINE FOR THE DETECTION OF PROSTATE CANCER RELAPSE AFTER RADICAL TREATMENT 162
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL. 159
POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER 156
Report of the 6th International Workshop on PET in lymphoma 155
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 154
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group 154
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 152
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA 146
Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report 144
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial 144
Yttrium 90 Intra Arterial Radioembolization Therapy of Unresectable Intrahepatic Cholangiocarcinoma: 5 Year Experience at a Single Center 140
Psychometric Properties of the Italian Version of the Short-Form Supportive Care Needs Survey Questionnaire (SCNS-SF34-It): A Multicenter Validation Study 139
The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET 134
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial 134
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 134
The role of 18F-FDG PET/CT in soft tissue sarcoma 132
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. 128
Therapy assessment in multiple myeloma with PET 126
Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view. 125
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma 123
USEFULNESS OF 11C-CHOLINE PET/CT IMAGING FOR DETECTION OF LYNPHONODE INVOLVENT IN NEWLY DIAGNOSED PROSTATE CANCER 112
Functional imaging for therapeutic assessment and minimal residual disease detection in multiple myeloma 110
The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option? 109
Methodological framework for radiomics applications in Hodgkin’s lymphoma 108
Glucose metabolism quantified by suvmax on baseline fdg-pet/ct predicts survival in newly diagnosed multiple myeloma patients: Combined harmonized analysis of two prospective phase iii trials 108
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? 106
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 105
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials 102
Spine Infections: The Role of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) in the Context of the Actual Diagnosis Guideline 99
Interest of pet imaging in multiple myeloma 99
Skeletal survey in multiple myeloma: Role of imaging 98
Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on [68Ga]Ga-FAPI PET/CT 90
Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma 81
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma 66
Therapeutic potential of lorlatinib in ALK-mutated metastatic paraganglioma: Insights from clinical case report and literature review 63
Monoclonal and polyclonal circulating plasma cells (CPCs) are linked to disease spread in multiple myeloma 52
Learned Deep Radiomics for Survival Analysis with Attention 42
The Role of Whole-Body MRI in Patients with Lymphoma: A Narrative Review 41
Mask-aware foundational-model embeddings for 18F-FDG-PET/CT prognosis in multiple myeloma 12
Totale 8.307
Categoria #
all - tutte 22.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021201 0 0 0 0 0 0 0 0 0 24 24 153
2021/2022871 110 32 43 60 80 27 18 56 26 55 231 133
2022/2023994 96 160 64 128 62 74 29 61 151 33 98 38
2023/2024305 41 38 17 22 31 55 19 21 7 18 27 9
2024/20251.444 51 128 123 113 150 86 166 76 55 126 92 278
2025/20263.148 379 292 300 244 348 183 325 148 704 225 0 0
Totale 8.307